Cambridge, Austria

Gabriela Pregernig

This inventor holds 1 USPTO granted patent. Top assignee: Decibel Therapeutics, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gabriela Pregernig. Retrieved from https://idiyas.com/inventor/gabriela-pregernig-duf7oq7c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gabriela Pregernig: Innovator in Cochlear Research

Introduction

Gabriela Pregernig is a notable inventor based in Cambridge, Austria. She has made significant contributions to the field of cochlear research, particularly in the development of inner hair cell promoters.

Latest Patents

Gabriela holds a patent titled "Cochlear Inner Hair Cell Promoters and Uses Thereof." This innovation is crucial for advancing treatments related to hearing loss and cochlear function. She has 1 patent to her name, showcasing her commitment to innovation in this specialized area.

Career Highlights

Gabriela is currently employed at Decibel Therapeutics, Inc., where she continues to push the boundaries of auditory research. Her work is instrumental in developing therapies that could potentially restore hearing.

Collaborations

Gabriela collaborates with talented individuals such as Adam Palermo and Martin Schwander, contributing to a dynamic research environment that fosters innovation.

Conclusion

Gabriela Pregernig's work in cochlear research exemplifies the impact of innovative thinking in the medical field. Her contributions are paving the way for future advancements in hearing restoration.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…